台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    67.7
  • 漲跌
    ▼0.3
  • 漲幅
    -0.44%
  • 成交量
    82
  • 產業
    上櫃 生技醫療類股▼0.27%
  • 65人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
易威 (1799)籌碼相關-台灣企銀 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

台灣企銀 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/04/2400.00368.0367.70-3257-1.17%
2024/03/2800.001869.0969.50-18244-7.36%
2024/03/2700.004269.1569.00-42244-17.17%
2024/03/256069.6600.0069.806023725.26%
2024/01/2300.001.439.7139.95-1.4148-0.94%
2024/01/1100.00140.9039.60-1200-0.50%
2023/10/3100.002130.1330.10-21132-15.83%
2023/10/0500.00122.2022.00-127-3.60%
2023/10/0400.00321.8821.90-330-9.98%
2023/09/19320.9000.0021.103358.54%
2023/08/2900.004.221.5621.50-4.271-5.85%
2023/07/11922.0500.0022.2597811.43%
2023/06/20621.4100.0021.5561025.84%
2023/06/19121.8000.0021.7011040.96%
2023/06/16222.1000.0022.1021061.87%
2023/06/0600.000.723.7524.10-0.7139-0.50%
2021/12/0700.00516.2516.20-5105-4.74%
2021/11/11516.0000.0016.005826.09%
2021/10/1800.00215.4015.20-276-2.64%
2021/05/2000.005016.9816.60-50550-9.09%
2021/05/1700.00319.2019.60-3506-0.59%
2021/05/1400.00618.2017.90-6459-1.31%
2021/05/13619.0500.0019.5564341.38%
2021/05/1200.00717.8017.80-7377-1.85%
2021/04/26317.2000.0017.3033460.87%
2021/03/10516.8500.0016.8052711.84%
2020/11/2600.00618.7718.75-6378-1.59%
2020/11/24618.3000.0018.3563791.58%
2020/11/0500.001218.8518.95-12442-2.71%
2020/10/28419.8000.0019.0045090.79%
2020/10/26720.7900.0020.4075281.32%
2020/10/23120.30419.7419.70-3548-0.55%
2020/10/22722.87921.9321.20-2561-0.36%
2020/10/20219.8000.0019.8025460.37%
2020/10/16716.0000.0016.4076021.16%
2020/08/17222.4000.0022.0522,3080.09%
2020/08/13124.2000.0023.5012,3170.04%
2020/07/2800.00223.3023.40-22,265-0.09%
2020/07/27125.0000.0024.9012,2480.04%
2020/07/2300.00128.7028.80-12,233-0.04%
2020/07/2100.00127.1027.45-12,149-0.05%
2020/07/1700.00128.1026.15-12,068-0.05%
2020/07/155030.26230.0530.80481,9832.42%
2020/07/14732.1400.0029.6071,9070.37%
2020/07/13131.20231.0831.55-11,793-0.06%
2020/07/10328.2800.0028.7031,6660.18%
2020/07/07122.2500.0021.6011,5050.07%
2020/07/06223.2000.0023.1521,4760.14%
2020/06/1800.001823.1022.85-181,372-1.31%
2020/06/15124.2000.0024.2011,2070.08%
2020/06/1200.00319.0022.00-31,124-0.27%
2020/06/11320.9000.0021.0031,0770.28%
2020/06/1000.00218.6019.10-2985-0.20%
2020/05/27123.7500.0019.4519470.11%
2020/05/26121.6000.0021.6019020.11%
2020/05/222017.9000.0017.90209302.15%
2020/05/1400.00211.8011.60-2789-0.25%
2020/04/29211.2800.0011.3027130.28%
2020/03/1100.007011.9911.50-70563-12.42%
2020/03/0400.00115.0514.95-1459-0.22%
2020/02/273614.0300.0013.303635910.03%
2020/02/263514.0000.0014.053532110.87%
2020/02/2500.00112.0012.80-1264-0.38%
2020/02/2019.9900.0010.0011740.57%
2020/01/0200.000.410.8510.85-0.479-0.52%
2019/07/1600.00511.4011.00-5104-4.78%
2019/07/11510.6500.0010.555995.05%
2019/07/0800.00410.6010.60-496-4.15%
2019/07/03411.6000.0011.354904.41%
2019/02/1800.001.112.3512.35-1.1119-0.90%
2019/02/1300.001.212.7412.60-1.2117-1.04%
2018/06/0600.00218.1018.35-2395-0.51%
2018/06/0100.00318.2018.35-3393-0.76%
2018/05/2900.00118.0517.95-1390-0.26%
2018/04/17221.0000.0020.5523420.58%
2018/04/13323.9500.0023.7033020.99%
2018/04/11123.3000.0022.9012320.43%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音